Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Int J Hematol

Retrieve available abstracts of 109 articles:
HTML format

Single Articles

    July 2021
  1. GASIOR KABAT M, Bueno D, Sisinni L, De Paz R, et al
    Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
    Int J Hematol. 2021;114:116-123.
    PubMed     Abstract available

  2. LIU X, Cheng L, He Y, Zhang R, et al
    Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
    Int J Hematol. 2021;114:124-128.
    PubMed     Abstract available

    June 2021
  3. YOSHINARI H, Kawahara Y, Niijima H, Oh Y, et al
    Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
    Int J Hematol. 2021 Jun 10. pii: 10.1007/s12185-021-03165.
    PubMed     Abstract available

    May 2021
  4. MAHE K, Couturaud F, Kerspern H, Chauveau A, et al
    Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
    Int J Hematol. 2021 May 22. pii: 10.1007/s12185-021-03164.
    PubMed     Abstract available

    April 2021
  5. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    PubMed     Abstract available

  6. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.

  7. LERTKOVIT O, Anurathapan U, Hongeng S, Thokanit NS, et al
    Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:556-565.
    PubMed     Abstract available

    March 2021
  8. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    PubMed     Abstract available

  9. OTSUKA H, Endo Y, Ohtsu H, Inoue S, et al
    Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.
    Int J Hematol. 2021;113:348-361.
    PubMed     Abstract available

    February 2021
  10. VIVES-CORRONS JL, Krishnevskaya E, Rodriguez IH, Ancochea A, et al
    Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
    Int J Hematol. 2021;113:163-174.
    PubMed     Abstract available

  11. PINCZES LI, Szabo R, Miltenyi Z, Illes A, et al
    The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int J Hematol. 2021;113:175-182.
    PubMed     Abstract available

    January 2021
  12. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    PubMed     Abstract available

  13. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    PubMed     Abstract available

    December 2020
  14. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    PubMed     Abstract available

    October 2020
  15. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    PubMed     Abstract available

  16. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    PubMed     Abstract available

    September 2020
  17. YABE M, Morio T, Tabuchi K, Tomizawa D, et al
    Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
    Int J Hematol. 2020 Sep 19. pii: 10.1007/s12185-020-02991.
    PubMed     Abstract available

  18. ISE M, Iizuka H, Kamoda Y, Hirao M, et al
    Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.
    Int J Hematol. 2020 Sep 2. pii: 10.1007/s12185-020-02971.
    PubMed     Abstract available

  19. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    PubMed     Abstract available

    August 2020
  20. AKRAM T, Fatima A, Klar J, Hoeber J, et al
    Aberrant splicing due to a novel RPS7 variant causes Diamond-Blackfan Anemia associated with spontaneous remission and meningocele.
    Int J Hematol. 2020 Aug 9. pii: 10.1007/s12185-020-02950.
    PubMed     Abstract available

  21. YE L, Zhang F, Kojima S
    Current insights into the treatments of severe aplastic anemia in China.
    Int J Hematol. 2020 Aug 3. pii: 10.1007/s12185-020-02955.
    PubMed     Abstract available

    June 2020
  22. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    PubMed     Abstract available

    May 2020
  23. KAGEYAMA Y, Katayama N
    Ontogeny of human B1 cells.
    Int J Hematol. 2020;111:628-633.
    PubMed     Abstract available

  24. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.

    April 2020
  25. EDAHIRO Y, Yasuda H, Ando K, Komatsu N, et al
    Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.
    Int J Hematol. 2020;111:579-584.
    PubMed     Abstract available

    March 2020
  26. CHE YAACOB NS, Islam MA, Alsaleh H, Ibrahim IK, et al
    Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in beta-thalassemia.
    Int J Hematol. 2020;111:352-359.
    PubMed     Abstract available

    February 2020
  27. NOPPARATANA C, Nopparatana C, Saechan V, Karnchanaopas S, et al
    Prenatal diagnosis of alpha- and beta-thalassemias in southern Thailand.
    Int J Hematol. 2020;111:284-292.
    PubMed     Abstract available

    January 2020
  28. KITAO A, Kawamoto S, Kurata K, Hayakawa I, et al
    Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia.
    Int J Hematol. 2020 Jan 30. pii: 10.1007/s12185-020-02831.
    PubMed     Abstract available

  29. JIANG J, Cai Y, Wan L, Yang J, et al
    Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
    Int J Hematol. 2020 Jan 3. pii: 10.1007/s12185-019-02807.
    PubMed     Abstract available

    November 2019
  30. YASUDA H, Tsutsui M, Ando J, Inano T, et al
    Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients.
    Int J Hematol. 2019;110:543-549.
    PubMed     Abstract available

    October 2019
  31. SAKURAI M, Jang JH, Chou WC, Kim JS, et al
    Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2019;110:411-418.
    PubMed     Abstract available

  32. MANKHEMTHONG K, Phusua A, Suanta S, Srisittipoj P, et al
    Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in northern Thailand.
    Int J Hematol. 2019;110:474-481.
    PubMed     Abstract available

    August 2019
  33. KEDAR PS, Harigae H, Ito E, Muramatsu H, et al
    Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
    Int J Hematol. 2019 Aug 10. pii: 10.1007/s12185-019-02716.
    PubMed     Abstract available

  34. JANG W, Kim J, Chae H, Kim M, et al
    Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing.
    Int J Hematol. 2019;110:250-254.
    PubMed     Abstract available

    June 2019
  35. YAMAZAKI H, Ohta K, Iida H, Imada K, et al
    Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
    Int J Hematol. 2019 Jun 10. pii: 10.1007/s12185-019-02683.
    PubMed     Abstract available

    May 2019
  36. KAWAKAMI T, Sekiguchi N, Kobayashi J, Yamane T, et al
    STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
    Int J Hematol. 2019;109:563-571.
    PubMed     Abstract available

    April 2019
  37. MORI T, Onishi Y, Ozawa Y, Kato C, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia.
    Int J Hematol. 2019 Apr 8. pii: 10.1007/s12185-019-02644.
    PubMed     Abstract available

    March 2019
  38. LI F, Li W, Qiao X, Xie X, et al
    Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Int J Hematol. 2019;109:328-335.
    PubMed     Abstract available

    January 2019
  39. SAKURAI M, Kikuchi T, Karigane D, Kasahara H, et al
    Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.
    Int J Hematol. 2019 Jan 24. pii: 10.1007/s12185-019-02596.
    PubMed     Abstract available

  40. SHAIKH H, Faisal MS, Mewawalla P
    Vitamin C deficiency: rare cause of severe anemia with hemolysis.
    Int J Hematol. 2019 Jan 22. pii: 10.1007/s12185-018-02575.
    PubMed     Abstract available

  41. KIM EA, Lim YT, Hah JO, Sohn YB, et al
    Correction to: Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Int J Hematol. 2019 Jan 10. pii: 10.1007/s12185-018-02590.
    PubMed     Abstract available

  42. SASAKI N, Shimura K, Yoshida M, Uoshima N, et al
    Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients.
    Int J Hematol. 2019 Jan 9. pii: 10.1007/s12185-018-02583.
    PubMed     Abstract available

    December 2018
  43. AKABAYASHI A, Nakazawa E, Jecker NS
    The world's first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells.
    Int J Hematol. 2018 Dec 7. pii: 10.1007/s12185-018-02565.

  44. RECASENS V, Montanes A, Bustamante E
    Lead poisoning as final diagnosis in a study of normocytic anemia.
    Int J Hematol. 2018 Dec 6. pii: 10.1007/s12185-018-02570.

    November 2018
  45. KIM EA, Lim YT, Hah JO, Sohn YB, et al
    Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Int J Hematol. 2018 Nov 19. pii: 10.1007/s12185-018-2559.
    PubMed     Abstract available

  46. KONISHI T, Doki N, Takaki Y, Igarashi A, et al
    Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia.
    Int J Hematol. 2018 Nov 1. pii: 10.1007/s12185-018-2554.

    October 2018
  47. INABA T, Ohama A
    Prominent increase of Pappenheimer body-containing erythrocytes in a patient with hypoplastic spleen (IJHM-D-18-00279R2).
    Int J Hematol. 2018;108:351-352.

  48. NITTAYABOON K, Nopparatana C
    Molecular characterization of Hb H disease in southern Thailand.
    Int J Hematol. 2018;108:384-389.
    PubMed     Abstract available

    September 2018
  49. IKUTA K, Ito H, Takahashi K, Masaki S, et al
    Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study.
    Int J Hematol. 2018 Sep 7. pii: 10.1007/s12185-018-2529.
    PubMed     Abstract available

    August 2018
  50. ARAKI R, Nishimura R, Kuroda R, Fujiki T, et al
    A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).
    Int J Hematol. 2018;108:151-160.
    PubMed     Abstract available

  51. WU X, Wang S, Lu X, Shen W, et al
    Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
    Int J Hematol. 2018;108:123-129.
    PubMed     Abstract available

    July 2018
  52. IKUTA K, Hanashi H, Hirai K, Ota Y, et al
    Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Int J Hematol. 2018 Jul 23. pii: 10.1007/s12185-018-2501.
    PubMed     Abstract available

  53. SONODA M, Ishimura M, Ichimiya Y, Terashi E, et al
    Correction to: Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.
    Int J Hematol. 2018 Jul 2. pii: 10.1007/s12185-018-2493.
    PubMed     Abstract available

  54. ASADOV C, Alimirzoeva Z, Mammadova T, Aliyeva G, et al
    beta-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Int J Hematol. 2018;108:5-21.
    PubMed     Abstract available

    June 2018
  55. HAMADA M, Doisaki S, Okuno Y, Muramatsu H, et al
    Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.
    Int J Hematol. 2018 Jun 23. pii: 10.1007/s12185-018-2482.
    PubMed     Abstract available

  56. UEDA Y, Obara N, Yonemura Y, Noji H, et al
    Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2018;107:656-665.
    PubMed     Abstract available

    March 2018
  57. KHAMPHIKHAM P, Sripichai O, Munkongdee T, Fucharoen S, et al
    Genetic variation of Kruppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in beta(0)-thalassemia/HbE disease.
    Int J Hematol. 2018;107:297-310.
    PubMed     Abstract available

    February 2018
  58. XING L, Xu W, Qu Y, Zhao M, et al
    miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
    Int J Hematol. 2018 Feb 27. pii: 10.1007/s12185-018-2429.
    PubMed     Abstract available

  59. SONODA M, Ishimura M, Ichimiya Y, Terashi E, et al
    Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.
    Int J Hematol. 2018 Feb 23. pii: 10.1007/s12185-018-2424.
    PubMed     Abstract available

  60. RAB MAE, Meerveld-Eggink A, van Velzen-Blad H, van Loon D, et al
    Persistent changes in circulating white blood cell populations after splenectomy.
    Int J Hematol. 2018;107:157-165.
    PubMed     Abstract available

  61. KARNER KH, Inamdar KV
    Plasma cell myeloma mimicking classical Hodgkin lymphoma in the bone marrow.
    Int J Hematol. 2018;107:127-128.

    January 2018
  62. IKUTA K, Shimura A, Terauchi M, Yoshii K, et al
    Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with iron-deficiency anemia.
    Int J Hematol. 2018 Jan 22. pii: 10.1007/s12185-018-2400.
    PubMed     Abstract available

  63. GIRELLI D, Ugolini S, Busti F, Marchi G, et al
    Modern iron replacement therapy: clinical and pathophysiological insights.
    Int J Hematol. 2018;107:16-30.
    PubMed     Abstract available

    Iron metabolism and related diseases: an overview.
    Int J Hematol. 2018;107:5-6.

    December 2017
  65. CHAROENKWAN P, Sirichotiyakul S, Phusua A, Suanta S, et al
    High-resolution melting analysis for prenatal diagnosis of beta-thalassemia in northern Thailand.
    Int J Hematol. 2017;106:757-764.
    PubMed     Abstract available

  66. ALGIRAIGRI AH, Kassam A
    Hydroxyurea for hemoglobin E/beta-thalassemia: a systematic review and meta-analysis.
    Int J Hematol. 2017;106:748-756.
    PubMed     Abstract available

    November 2017
  67. FURUYAMA K, Kaneko K
    Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.
    Int J Hematol. 2017 Nov 14. doi: 10.1007/s12185-017-2368.
    PubMed     Abstract available

  68. SRINOUN K, Nopparatana C, Wongchanchailert M, Fucharoen S, et al
    MiR-155 enhances phagocytic activity of beta-thalassemia/HbE monocytes via targeting of BACH1.
    Int J Hematol. 2017;106:638-647.
    PubMed     Abstract available

  69. KADDAH NA, Saied DA, Alwakeel HA, Hashem RH, et al
    Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.
    Int J Hematol. 2017;106:648-654.
    PubMed     Abstract available

  70. OHKAWARA H, Furukawa M, Ikeda K, Shichishima-Nakamura A, et al
    Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-beta in the bone marrow: a case report.
    Int J Hematol. 2017;106:718-724.
    PubMed     Abstract available

    October 2017
  71. IMATAKI O, Uchida S, Yokokura S, Uemura M, et al
    Anemia and hypogammaglobulinemia caused by Menetrier's disease.
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2349.

    September 2017
  72. CUI Q, Sha P, Chen H, Shen H, et al
    Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Int J Hematol. 2017 Sep 12. doi: 10.1007/s12185-017-2321.
    PubMed     Abstract available

  73. SATITTHUMMANID S, Uaprasert N, Songmuang SB, Rojnuckarin P, et al
    Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in beta-thalassemia/HbE patients.
    Int J Hematol. 2017;106:366-374.
    PubMed     Abstract available

    August 2017
  74. XU X, Li L, Xia W, Ding H, et al
    Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody.
    Int J Hematol. 2017 Aug 16. doi: 10.1007/s12185-017-2310.
    PubMed     Abstract available

  75. UPANAN S, McKie AT, Latunde-Dada GO, Roytrakul S, et al
    Hepcidin suppression in beta-thalassemia is associated with the down-regulation of atonal homolog 8.
    Int J Hematol. 2017;106:196-205.
    PubMed     Abstract available

    July 2017
  76. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Abstract available

  77. TOKI Y, Ikuta K, Kawahara Y, Niizeki N, et al
    Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency.
    Int J Hematol. 2017;106:116-125.
    PubMed     Abstract available

    June 2017
  78. CHOI Y, Jo JC, Jeon HJ, Kim DW, et al
    Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.
    Int J Hematol. 2017 Jun 29. doi: 10.1007/s12185-017-2280.
    PubMed     Abstract available

  79. CHEUNG RS, Taniguchi T
    Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2283.
    PubMed     Abstract available

  80. LIU C, Zheng M, Zhang T, Fu R, et al
    TRAIL in CD8+ T cells from patients with severe aplastic anemia.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2279.
    PubMed     Abstract available

  81. ZHAO P, Gao Q, He Q, Tan J, et al
    Prevalence and clinical outcomes of hepatitis B virus infection in patients with aplastic anemia.
    Int J Hematol. 2017 Jun 13. doi: 10.1007/s12185-017-2276.
    PubMed     Abstract available

    May 2017
  82. URESHINO H, Kizuka H, Kusaba K, Sano H, et al
    5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Int J Hematol. 2017;105:692-696.
    PubMed     Abstract available

    April 2017
  83. ABAZA Y, Yin CC, Bueso-Ramos CE, Wang SA, et al
    Primary autoimmune myelofibrosis: a case report and review of the literature.
    Int J Hematol. 2017;105:536-539.
    PubMed     Abstract available

    March 2017
  84. WU L, Mo W, Zhang Y, Zhou M, et al
    Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2217.
    PubMed     Abstract available

  85. IKI S, Ohgi K, Suzuki K
    Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2017;105:231-232.

  86. ZAHRAN AM, Saad K, Elsayh KI, Alblihed MA, et al
    Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with beta-thalassemia major.
    Int J Hematol. 2017;105:265-271.
    PubMed     Abstract available

  87. KOMATSU N, Kirito K, Shimoda K, Ishikawa T, et al
    Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
    Int J Hematol. 2017;105:309-317.
    PubMed     Abstract available

    February 2017
  88. WU L, Xu W, Xu L, Kong Q, et al
    Mitophagy is increased during erythroid differentiation in beta-thalassemia.
    Int J Hematol. 2017;105:162-173.
    PubMed     Abstract available

    January 2017
  89. HAYAKAWA J, Kanda J, Akahoshi Y, Harada N, et al
    Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Int J Hematol. 2017 Jan 11. doi: 10.1007/s12185-017-2179.
    PubMed     Abstract available

  90. IKEBE T, Takata H, Sasaki H, Miyazaki Y, et al
    Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
    Int J Hematol. 2017 Jan 4. doi: 10.1007/s12185-016-2177.

    December 2016
  91. SEKIGUCHI N, Nishina S, Kawakami T, Sakai H, et al
    Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
    Int J Hematol. 2016 Dec 27. doi: 10.1007/s12185-016-2170.
    PubMed     Abstract available

    November 2016
  92. ICHIMURA T, Yoshida K, Okuno Y, Yujiri T, et al
    Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.
    Int J Hematol. 2016.
    PubMed     Abstract available

  93. NINOMIYA H, Obara N, Chiba S, Usuki K, et al
    Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2016;104:548-558.
    PubMed     Abstract available

    October 2016
  94. GUO Z, Gao HY, Zhang TY, Liu XD, et al
    Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Abstract available

    August 2016
  95. NAKAO S
    Diagnostic problems in acquired bone marrow failure syndromes.
    Int J Hematol. 2016;104:151-2.

  96. INOUE S, Kodjebacheva G, Scherrer T, Rice G, et al
    Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.
    Int J Hematol. 2016;104:200-7.
    PubMed     Abstract available

  97. FALCHI L, Grillo LM, Diuguid-Gerber JL, Eisenberger AB, et al
    Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy.
    Int J Hematol. 2016;104:147-8.

  98. MIYATA T, Uchida Y, Yoshida Y, Kato H, et al
    No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.
    Int J Hematol. 2016;104:223-7.
    PubMed     Abstract available

  99. MARSH JC, Mufti GJ
    Clinical significance of acquired somatic mutations in aplastic anaemia.
    Int J Hematol. 2016;104:159-67.
    PubMed     Abstract available

    June 2016
  100. YU F, Du Y, Han B
    A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.
    Int J Hematol. 2016;103:649-54.
    PubMed     Abstract available

  101. TANTIWORAWIT A, Charoenkwan P, Hantrakool S, Choeyprasert W, et al
    Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Int J Hematol. 2016;103:643-8.
    PubMed     Abstract available

  102. PIGATTO PD, Ronchi A, Guzzi G
    Iron overload, G6PD deficiency, and lead levels on blood smears.
    Int J Hematol. 2016;103:724.

  103. MIYASAKA N, Miura O, Kawaguchi T, Arima N, et al
    Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
    Int J Hematol. 2016;103:703-12.
    PubMed     Abstract available

    May 2016
  104. DIAMANTIDIS MD, Neokleous N, Agapidou A, Vetsiou E, et al
    Iron chelation therapy of transfusion-dependent beta-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Int J Hematol. 2016;103:537-44.
    PubMed     Abstract available

    April 2016
    The current perspective of low-grade myelodysplastic syndrome in children.
    Int J Hematol. 2016;103:360-4.
    PubMed     Abstract available

  106. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.

  107. DALLE JH, Peffault de Latour R
    Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2016;103:373-9.
    PubMed     Abstract available

    March 2016
  108. FAN X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, et al
    Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
    Int J Hematol. 2016;103:283-91.
    PubMed     Abstract available

    January 2016
  109. ADDO L, Ikuta K, Tanaka H, Toki Y, et al
    The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).
    Int J Hematol. 2016;103:34-43.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.